Skip to main content
OpenTrials
Completed

NCT Number: NCT02153359

Effects of Reducing Indoor Air Pollution on the Adult Asthmatic Response

This study is about asthma and how the environment affects asthma. Scientists know that air pollution (such as cigarette smoke and other particles in the air) can make asthma symptoms worse. This research is being done to study how the health of a person with asthma responds to an air cleaner. The investigator hypothesize that an air cleaner will improve the health of persons with asthma.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–50 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States

Loading trial locations.

About this study

The investigators seek to determine the effect of placing air cleaner devices in the homes of adults with asthma on the adults' asthma health. To this end, the investigators aim to study 40 adults with asthma that are 18-50 years of age and live in Baltimore. Participants will receive either true air cleaners or sham cleaners in a blinded, randomized manner for one month, and then, after a washout period, participants will cross over and receive the other intervention (sham or true cleaner). All participants will have environmental monitoring (personal and in-home) to determine participants' particulate matter exposure, and be followed repeatedly during the 3 month study period for markers of asthma disease, including respiratory symptoms, medication and health care utilization, pulmonary function, systemic markers of inflammation, and bronchoscopic evidence of airway inflammation or epithelial cell dysfunction.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 18-50 years of age
  • Non-smoker (<100 cigarettes in lifetime)
  • Physician diagnosis of asthma
  • Symptoms of asthma and/or reliever medication use in the past 6 months
  • Living in the current residence >= 6 months within Baltimore
  • Enrollment in, and completion of, the observational environmental asthma study "Inhale 1"

Exclusion criteria

  • Current diagnosis of another major pulmonary disease, other significant morbidity
  • Pregnancy (as defined by a positive urine pregnancy test at screening of all women of child-bearing potential)
  • Planning to relocate residence or activity that necessitates travel away from home for prolonged period of time during the study period
  • Current use of an air cleaner in the home

Treatment and study plan

High Efficiency Particulate Air Cleaner

Device

Sham air cleaner

Device

Primary outcomes

  1. PM2.5 Concentration (ug/m^3)

    Time frame: Approximately 1 month

    Fine particulate matter (PM2.5) concentration as assessed by a passive filter placed in the participant's home.

  2. PM2.5-10 Concentration (ug/m^3)

    Time frame: Approximately 1 month

    Coarse particulate matter (PM2.5-10) concentration as assessed by a passive filter placed in the participant's home.

Secondary outcomes

  1. Number of Symptom-free Days

    Time frame: 7 days

    The number of reported days without daytime asthma symptoms (symptom-free days) as based on daily symptom diaries recorded by the patient.

  2. Number of Days With Activity Limitations

    Time frame: 7 days

    Number of reported days with activity limitations due to asthma symptoms.

  3. Number of Nights Disrupted by Asthma Symptoms

    Time frame: 7 nights

    The number of nights spent sleeping that was disrupted due to asthma symptoms.

  4. Number of Days of School/Work Missed Due to Asthma Symptoms

    Time frame: 7 days

    The number of days of school or work missed due to asthma symptoms.

  5. Number of Days of Unscheduled Visits to the Doctor Due to Asthma Symptoms

    Time frame: 7 days

    The number of days of unscheduled, urgent visits to the office, urgent care or emergency department due to asthma symptoms.

  6. Asthma Disease Status as Assessed by the Asthma Control and Communication Instrument (ACCI)

    Time frame: Approximately 1 month

    The ACCI is a validated clinical tool that measures asthma disease status during routine health care and is valid for use in both black and white populations. The sum of each of the 5 ACCI asthma control domains results in a final ACCI score ranging from 0 (better control) to 19 (worse control).

  7. Asthma-specific Health-related Quality of Life as Assessed by the Asthma Quality of Life Questionnaire (AQLQ)

    Time frame: Approximately 1 month

    The AQLQ is validated clinical tool to assess asthma-specific health-related quality of life instrument that taps both physical and emotional impact of disease. Scores range from 1-7, with higher scores indicating better quality of life.

  8. Air Nicotine Concentration (ug/m^3)

    Time frame: Approximately 1 month

    Indoor air nicotine concentration as assessed by a passive filter placed in the participant's home.

  9. Bronchoalveolar Lavage Differential Neutrophil Count

    Time frame: 1 Day

    The percentage of neutrophils in the bronchoalveolar lavage cell count.

  10. Bronchoalveolar Lavage Differential Eosinophil Count

    Time frame: 1 day

    The eosinophil percentage in the bronchoalveolar lavage cell count differential.

  11. Pre-bronchodilator Forced Vital Capacity (Litres)

    Time frame: 1 day

    Pre-bronchodilator forced vital capacity (FVC) as assessed with spirometry

  12. Pre-bronchodilator Forced Expiratory Volume in 1 Second (Litres)

    Time frame: 1 day

    The pre-bronchodilator forced expiratory volume in 1 second (FEV1) as assessed by spirometry.

  13. FEV1 Percentage of FVC

    Time frame: 1 day

    The pre-bronchodilator forced expiratory volume in 1 second over the forced vital capacity as assessed by spirometry.

Sponsors and collaborators

Lead sponsor

Johns Hopkins University

Other

Collaborators

  • National Institute of Environmental Health Sciences (NIEHS)

Registry information

Acronym: INHALE 2

Important dates

Study start
2014
Primary completion
2018
Study completion
2018
First posted
Jun 3, 2014
Registry last updated
Sep 12, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.